Laura Sol Grinshpan

AGEs advanced glycation end-products ASV amplicon sequence variant BH Benjamini–Hochberg BMI body mass index CAP controlled attenuation parameter CSS cumulative sum scaling F/B Firmicutes/Bacteroidota (ratio) FFQ food frequency questionnaire HOMA-IR homeostasis model assessment for insulin resistance LDA linear discriminant analysis LEfSe LDA effect size LPS lipopolysaccharide LSM liver stiffness measurement MASH metabolic dysfunction-associated steatohepatitis MASLD metabolic...

Abstract and Introduction Abstract Different dietary regimens for weight loss have developed over the years. Since the most evidenced treatment for non-alcoholic fatty liver disease (NAFLD) is weight reduction, it is not surprising that more diets targeting obesity are also utilized for NAFLD treatment.